Caldera Therapeutics

Leading the march to IBD bispecifics

Boston, United States · Founded 2025 · $112.5M raised

Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$112.5M
Last Round
$37.5M Series AJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Caldera Therapeutics is a clinical-stage biotechnology company founded in 2025 and headquartered in Massachusetts, developing CLD-423, a first-in-class bispecific antibody targeting the IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic conditions. The company was built around a senior leadership team with deep IBD drug development experience, including CEO Praveen Tipirneni, formerly of Morphic Therapeutic. Caldera licensed CLD-423 from a Chinese partner and launched with $112.5 million in total funding from top biotech investors including Atlas Venture, LAV, venBio, Omega Funds, Wellington Management, and Janus Henderson. A Phase 1 healthy volunteer trial of CLD-423 is currently ongoing.

Summary

Caldera Therapeutics is a Biotech company based in Boston, United States, founded in 2025. It has raised $112.5M in total across 2 rounds, most recently a $37.5M Series A round in Jan 2026. Investors include Omega Funds, Atlas Venture and Wellington Management.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2026
$37.5M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Caldera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/caldera-therapeutics"><img src="https://indexed.vc/api/badge/company/caldera-therapeutics" alt="Caldera Therapeutics on Indexed.vc" width="260" height="76" /></a>